Upload Image (Max 20MB per Image)
Janssen Research & Development has announced that it has submitted a supplemental New Drug Application to FDA for ZYTIGA(abiraterone acetate). Janssen-Cilag International NV has also sent a type II variation to the European Medicines ...
Tags: abiraterone acetate, FDA, metastatic prostate cancer